Joseph B. Conahan
Partner
- Co-Chair, Mergers and Acquisitions Practice
Joe Conahan’s practice focuses on the representation of buyers, sellers and boards of directors in mergers, acquisitions, divestitures, joint ventures and other strategic transactions in the life sciences, technology, FinTech and industrial sectors, as well as on counseling public companies on complex governance and disclosure matters.
Professional Activities
Mr. Conahan recently served as co-chair of the Boston Bar Association’s Mergers & Acquisitions Committee and co-chaired the advisory committees for the Boston Bar Association's 2016 M&A Conference and 2017 M&A Conference.
Community Involvement
Mr. Conahan's pro bono work includes the representation of organizations such as GlobalGiving Foundation and Boston Children's Chorus on a variety of matters.
Experience
-
Life Sciences Transactions
- Alkermes in its acquisition of Rodin Therapeutics
- Akouos in its sale to Eli Lilly
- Arteaus Therapeutics in the sale of its Emgality Royalty to Royalty Pharma
- AVEO Oncology in its sale to LG Chem
- Braintree Laboratories in its sale to Sebela Pharmaceuticals
- Astria Therapeutics (f/k/a Catabasis Pharmaceuticals) in its acquisition of Quellis Biosciences
- Cynosure in the acquisition of the assets of Ellman International
- Decibel Therapeutics in its pending sale to Regeneron Pharmaceuticals
- Disarm Therapeutics in its sale to Eli Lilly
- Durata Therapeutics in its sale to Allergan (formerly Actavis)
- Exonics Therapeutics in its sale to Vertex Pharmaceuticals
- Imara in the sale of assets to Cardurion Pharmaceuticals
- Imara in its merger with Enliven Therapeutics
- Intercept Pharmaceuticals in its acquisition of US rights to bezafibrate
- Kolltan Pharmaceuticals in its acquisition of Xetrios
- Levitronix in the sale of its medical device business to Thoratec Corporation
- Lexicon Pharmaceuticals in the sale of Xermelo to TerSera
- Nabriva Therapeutics in its acquisition of Zavante Therapeutics
- The Medicines Company in its acquisition of Recothrom from Bristol-Myers Squibb Company
- The Medicines Company in the sale of its hemostasis business to subsidiaries of Mallinckrodt
- MPM BioImpact in its take-private acquisition of Reunion Neuroscience
- The Special Committee of the Board of Directors of Emisphere Technologies in its acquisition by Novo Nordisk
- Schrödinger in its acquisition of XTAL BioStructures
- Syros Pharmaceuticals in its acquisition TYME Technologies
- Tecan Group in multiple acquisitions, including its acquisition of Paramit Corporation
- Thermo Fisher Scientific in its acquisition of Advanced Scientifics
- Thermo Fisher Scientific in its proposed acquisition of the Gatan business from Roper Technologies
- Thermo Fisher Scientific in the sale of its Anatomical Pathology business to PHC Holdings Corporation
- Thermo Fisher Scientific in the sale of its cell culture, gene modulation and magnetic beads businesses to GE Healthcare
-
Tech/FinTech Transactions
- Affirmed Networks in its sale to Microsoft Corporation
- Akamai Technologies in its acquisition of Janrain
- Analog Devices in its acquisition of Linear Technologies
- Analog Devices in its acquisition of Hittite Microwave
- Analog Devices in its acquisition of the assets of Sand9
- Analog Devices in the sale of its MEMS microphone business to InvenSense
- Analog Devices in the sale of Symeo GmbH to indie Semiconductor
- Bottomline Technologies in its acquisition of Andera
- Constant Contact in its acquisition of NutShell Mail
- Constant Contact in its acquisition of the assets of Bantam Networks
- LTX in its business combination with Credence Systems
- MKS Instruments in its proposed acquisition of Coherent
- MKS Instruments in its acquisition Electro Scientific Industries
- MKS Instruments in its acquisition of Newport Corporation
- QD Vision in the sale of its business to Samsung
- Rudolph Technologies in its all-stock merger of equals with Nanometrics to form Onto Innovation
- Sonus Networks in its business combination with GENBAND
- Starent Networks in its sale to Cisco Systems
- TARGUSinfo in its sale to Neustar
-
Other Transactions
- BAE Systems Safety Products in its sale to Takata Corporation
- CIRCOR International in its acquisition of a global fluid handling business from Colfax
- Cumberland Farms in its sale to EG Group
- Cumberland Farms, Inc. in the sale of its Gulf Oil and Assured Deal business to affiliates of ArcLight Capital Partners
- Dean Foods Company in the initial public offering and subsequent spin-off of its former subsidiary The WhiteWave Foods Company
- Eaton Vance in its sale to Morgan Stanley
- Houghton Mifflin Harcourt in its sale to affiliates of Veritas Capital
- Lydall in its acquisition of Interface Performance Materials
- Merchants Fleet in its sale to affiliates of Bain Capital and ADIA
Recognition
- Selected for inclusion in The Legal 500’s 2023 M&A Powerlist - USA Region.
- Named to Boston Magazine’s inaugural Top Lawyers list in 2021 and 2022 in the area of corporate law.
- Named a 2019 New England Trailblazer by the Connecticut Law Tribune.
- Recognized as a "Leading Lawyer" in the 2023 edition of The Legal 500 United States and recognized as a "Next Generation Lawyer" in the 2018–2022 editions for his M&A: Middle-Market practice.
- Recipient of M&A Advisor's Sixth Annual 40 Under 40 Emerging Leaders Award.
Insights & News
Credentials
-
Education
-
JD, Georgetown University Law Center, 2004
magna cum laude Order of the Coif, Articles and Notes Editor, American Criminal Law Review -
BS, Georgetown University, 2001
cum laude
-
-
Admissions
-
Massachusetts
-
District of Columbia
-
Pennsylvania
-
Credentials
-
Education
-
JD, Georgetown University Law Center, 2004
magna cum laude Order of the Coif, Articles and Notes Editor, American Criminal Law Review -
BS, Georgetown University, 2001
cum laude
-
-
Admissions
-
Massachusetts
-
District of Columbia
-
Pennsylvania
-